Cover Image
市場調查報告書

中國的介入心臟病學用設備產業

China Interventional Cardiovascular Device Industry Report,2014-2017

出版商 ResearchInChina 商品編碼 290056
出版日期 內容資訊 英文 112 pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的介入心臟病學用設備產業 China Interventional Cardiovascular Device Industry Report,2014-2017
出版日期: 2014年09月27日 內容資訊: 英文 112 pages
簡介

中國的經皮冠狀動脈介入治療(PCI)的病例,2013年達到454,505件,與去年同期比較增加16.9%。介入心臟病學用設備產業的市場價值,為201億人民幣。

本報告提供中國的介入心臟病學用設備產業調查分析、產業現狀、發展環境、市場區隔、競爭情形、主要企業詳細內容等相關的系統性資訊。

第1章 介入心臟病學用設備產業概要

  • 定義
  • 分類和應用
  • 產業鏈

第2章 中國的介入心臟病學用設備產業現狀

  • 概要
  • 市場需求
  • 進出口
  • 競爭情形
  • 進入障礙

第3章 中國的介入心臟病學用設備產業的發展環境

  • 宏觀環境
  • 政策形勢
  • 上游、下游部門

第4章 中國的介入心臟病學用設備產業的市場區隔

  • 冠狀動脈支架
  • 球囊導管
  • 導管
  • 導管導引線
  • 導鞘、輔助設備

第5章 中國的外資企業

  • 簡介、經營、收益結構等
    • Johnson & Johnson
    • Medtronic
    • Boston Scientific
    • Abbott Laboratories
    • B. Braun
    • Terumo Corporation

第6章 中國的國內企業

  • 簡介、經營、收益結構等
    • MicroPort
    • Lepu Medical
    • Lifetech Scientific
    • JW Medical
    • Dalian Yinyi
    • Neich Medical (Shenzhen)
    • SCW Medicath
    • Demax Medical
    • Starway Medical
    • Synexmed
    • Sino Medical
    • AmsinoMed Medical Device

第7章 預測與前景

  • 產業
  • 市場區隔

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: ZLC009

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing year after year, thereby promoting the development of domestic percutaneous coronary intervention (PCI) market. PCI cases in China totaled 454,505 in 2013, up 16.9% from a year earlier; meanwhile the interventional cardiovascular device industry there was worth RMB20.12 billion.

At present, half of the Chinese interventional cardiovascular device industry is dominated by domestic companies led by MicroPort, Lepu Medical, Lifetech Scientific, and Dalian Yinyi. In 2013, 53.4% of the Chinese market was controlled by domestic companies, 31.2% by foreign counterparts represented by Johnson & Johnson, Medtronic, Boston Scientific, Abbott, B. Braun and Terumo, and 15.4% by those invested by Hong Kong, Macao and Taiwan.

Interventional cardiovascular devices in China include cardiovascular stent, catheter, guidewire, balloon, surgical auxiliary devices, etc., among which cardiovascular stent is predominant.

Cardiovascular stent: In 2013, the Chinese cardiovascular stent market equaled RMB11.2 billion, 78.8% of which was occupied by domestic drug-eluting stents. That same year, 686,000 units of cardiovascular stent were consumed in China, up 11.7% year on year, and drug-eluting stents accounted for 99.5%, indicating that the drug-eluting stent is gradually becoming an important device for interventional cardiovascular therapy.

In addition, Abbott has developed biodegradable stents, which are sold in Europe; Lepu Medical is endeavoring to develop biodegradable stents, which are expected to be available on the market in 2017. Thanks to its excellent performance, biodegradable stents are likely to replace drug-eluting stents gradually in the future, thus becoming the main variety in domestic coronary stent market.

Balloon catheter: In 2013, China's demand for PTCA balloon catheter amounted to 1.186 million units, 500,000 of which were PTCA balloon catheters for dilatation. With rapid development of local PTCA balloon catheter producers represented by Lepu Medical, MicroPort and JW Medical, domestic PTCA balloon catheters increased its market share from 20% in 2009 to 40% in 2013.

Affected by the implementation of “Regulations on the Centralized Procurement of High-value Medical Consumables”, purchase price of interventional cardiovascular devices will continue to decline, further squeezing profit margins of relevant companies. However, the substantial decline in prices will enable more patients to receive PCI, thus helping the industry maintain a fairly rapid growth rate. It is expected that the Chinese interventional cardiovascular device market will worth RMB41.2 billion by 2017.

‘China Interventional Cardiovascular Device Industry Report, 2014-2017’ focuses on the following:

  • Status quo of China interventional cardiovascular device industry, including overview, market demand, import & export, competitive landscape and entry barriers;
  • Development environment of China interventional cardiovascular device industry, embracing macro environment, policy climate and upstream & downstream sectors;
  • Status quo, competitive landscape, etc. of China interventional cardiovascular device market segments, covering coronary stent, balloon catheter, catheter, guidewire, sheath group and auxiliary devices;
  • Operation, interventional cardiovascular device business, etc. of 6 foreign and 12 Chinese interventional cardiovascular device companies.

Table of Contents

1. Overview of Interventional Cardiovascular Device Industry

  • 1.1. Definition
  • 1.2. Classification and Application of Products
  • 1.3. Industry Chain

2. Status Quo of China Interventional Cardiovascular Device Industry

  • 2.1. Overview
  • 2.2. Market Demand
  • 2.3. Import & Export
  • 2.4. Competitive Landscape
  • 2.5. Entry Barriers
    • 2.5.1. Technology
    • 2.5.2. Talent
    • 2.5.3. Patent
    • 2.5.4. Policy
    • 2.5.5. Market Channel

3. Development Environment of China Interventional Cardiovascular Device Industry

  • 3.1. Macro Environment
  • 3.2. Policy Climate
    • 3.2.1. Regulatory Policies
    • 3.2.2. Industrial Policies
  • 3.3. Upstream & Downstream Sectors
    • 3.3.1. Upstream
    • 3.3.2. Downstream

4. Market Segments of China Interventional Cardiovascular Device Industry

  • 4.1. Coronary Stent
    • 4.1.1. Market Profile
    • 4.1.2. Drug-Eluting Stent
    • 4.1.3. Bioabsorbable Stent
  • 4.2. Balloon Catheter
    • 4.2.1. Market Profile
    • 4.2.2. Supply & Demand
  • 4.3. Catheter
  • 4.4. Guidewire
  • 4.5. Sheath Group and Auxiliary Devices

5. Foreign Companies in China

  • 5.1. Johnson & Johnson
    • 5.1.1. Profile
    • 5.1.2. Operation
    • 5.1.3. Revenue Structure
    • 5.1.4. Gross Margin
    • 5.1.5. Interventional Cardiovascular Device Business
    • 5.1.6. Development in China
  • 5.2. Medtronic
    • 5.2.1. Profile
    • 5.2.2. Operation
    • 5.2.3. Interventional Cardiovascular Device Business
    • 5.2.4. Development in China
  • 5.3. Boston Scientific
    • 5.3.1. Profile
    • 5.3.2. Operation
    • 5.3.3. Interventional Cardiovascular Device Business
    • 5.3.4. Development in China
  • 5.4. Abbott Laboratories
    • 5.4.1. Profile
    • 5.4.2. Operation
    • 5.4.3. Interventional Cardiovascular Device Business
    • 5.4.4. Development in China
  • 5.5. B. Braun
    • 5.5.1. Profile
    • 5.5.2. Operation
    • 5.5.3. Interventional Cardiovascular Device Business
    • 5.5.4. Development in China
  • 5.6. Terumo
    • 5.6.1. Profile
    • 5.6.2. Operation
    • 5.6.3. Interventional Cardiovascular Device Business
    • 5.6.4. Development in China

6. Major Domestic Companies

  • 6.1. MicroPort
    • 6.1.1. Profile
    • 6.1.2. Operation
    • 6.1.3. Revenue Structure
    • 6.1.4. Interventional Cardiovascular Device Business
    • 6.1.5. R&D and Investment
    • 6.1.6. Forecast and Outlook
  • 6.2. Lepu Medical
    • 6.2.1. Profile
    • 6.2.2. Operation
    • 6.2.3. Revenue Structure
    • 6.2.4. Gross Margin
    • 6.2.5. Interventional Cardiovascular Device Business
    • 6.2.6. R&D and Investment
    • 6.2.7. Forecast and Outlook
  • 6.3. Lifetech Scientific
    • 6.3.1. Profile
    • 6.3.2. Operation
    • 6.3.3. Revenue Structure
    • 6.3.4. Interventional Cardiovascular Device Business
    • 6.3.5. R&D and Investment
    • 6.3.6. Forecast and Outlook
  • 6.4. JW Medical
    • 6.4.1. Profile
    • 6.4.2. Interventional Cardiovascular Device Business
  • 6.5. Dalian Yinyi
    • 6.5.1. Profile
    • 6.5.2. Interventional Cardiovascular Device Business
  • 6.6. Neich Medical (Shenzhen)
    • 6.6.1. Profile
    • 6.6.2. Interventional Cardiovascular Device Business
  • 6.7. SCW Medicath
    • 6.7.1. Profile
    • 6.7.2. Interventional Cardiovascular Device Business
  • 6.8. Demax Medical
    • 6.8.1. Profile
    • 6.8.2. Interventional Cardiovascular Device Business
  • 6.9. Starway Medical
    • 6.9.1. Profile
    • 6.9.2. Interventional Cardiovascular Device Business
  • 6.10. Synexmed
    • 6.10.1. Profile
    • 6.10.2. Interventional Cardiovascular Device Business
  • 6.11. Sino Medical
    • 6.11.1. Profile
    • 6.11.2. Interventional Cardiovascular Device Business
  • 6.12. AmsinoMed Medical Device
    • 6.12.1. Profile
    • 6.12.2. Interventional Cardiovascular Device Business

7. Forecast and Outlook

  • 7.1. Industry
  • 7.2. Market Segments
    • 7.2.1. Coronary Stent
    • 7.2.2. Balloon Catheter

Selected Charts:

  • Types and Functions of Interventional Cardiovascular Device
  • Types and Features of Cardiovascular Stent
  • Interventional Cardiovascular Device Industry Chain in China
  • Total Industrial Output Value and YoY Growth of China Medical Device Industry, 2005-2013
  • Revenue and YoY Growth of China Medical Device Industry, 2005-2013
  • Market Size and YoY Growth of China Interventional Cardiovascular Device Industry, 2009-2013
  • Number of Patients with Cardiovascular Disease in China, 2013
  • Death Rate Percentage of Major Diseases in Rural Area, 2012
  • Death Rate Percentage of Major Diseases in Urban Area, 2012
  • Changes in Mortality Rate of Coronary Heart Disease in Urban and Rural Areas of China, 2002-2011
  • Number of PCI Cases and Growth Rate in China, 2011-2013
  • Coronary Stent Implantation and Usage Percentage of Drug-eluting Stent in China, 2011-2013
  • Import Share and Import Prices of Main Interventional Medical Devices in China, 2008
  • China's Intravascular Stent Imports and Exports by Top 10 Countries, 2013
  • Market Structure of China Interventional Cardiovascular Device Industry, 2013
  • Number of Congenital Heart Disease Patients Receiving Interventional Therapy in China, 2012-2013
  • Business Models of China Interventional Cardiovascular Device Industry
  • China's GDP and YoY Growth, 1985-2013
  • Main Policies Concerning Interventional Cardiovascular Device in China, 2006-2013
  • Number of Medical Institutions and Sickbeds in China, 2012-2013
  • Number of Hospitals in China (by Grade), 2010-Jun. 2014
  • Medical Service Quantity of Health Care Facilities in China, 2012-2013
  • Usage of Sickbeds in China's Medical Institutions, 2012-2013
  • Health Costs and % of GDP in China, 1980-2013
  • Per Capita Health Costs and YoY Growth Rate in China, 2006-2013
  • Number of People 65 and Over and % of Total Population in China, 2004-2013
  • Ratio between Per Capita Income of Urban and Rural Households in China, 1980-2013
  • Medical Insurance Coverage and Expenditure in China
  • Proportion of Medical Insurance-covered Payment for Interventional Operation in Beijing, Shanghai and Guangzhou, 2011
  • Market Share of China-made Coronary Drug-eluting Stent System, 2009-2013
  • Market Share of Main Coronary Stent System Brands in China (by Consumption), 2013
  • Implantation of Coronary Stent in China, 2011-2013
  • China's Coronary Stent Market Size and YoY Growth, 2012-2017E
  • Comparison of Relevant Data about PCI in China, 2011-2013
  • List of Main Domestic Drug-eluting Stent Products, 2013
  • Market Share of Imported and Domestic PTCA Balloon Catheter Products, 2013
  • China's Interventional Cardiovascular Balloon Catheter Market Size, 2012-2017E
  • China's Demand for PTCA Balloon Catheter, 2011-2013
  • China's Interventional Cardiovascular Catheter Market Size, 2012-2017E
  • China's Interventional Cardiovascular Guide Wire Market Size, 2012-2017E
  • China's Interventional Cardiovascular Sheath Group and Auxiliary Device Market Size, 2012-2017E
  • Total Revenue and Net Income of Johnson & Johnson, 2009-2014
  • Total Revenue Breakdown of Johnson & Johnson (by Product), 2009-2014
  • Total Revenue Structure of Johnson & Johnson (by Product), 2009-2014
  • Gross Margin of Johnson & Johnson, 2009-2014
  • Johnson & Johnson's Revenue from Cardiovascular Business and YoY Growth, 2009-2013
  • Johnson & Johnson's Companies in China and Their Main Products
  • Revenue and Net Income of Medtronic, FY2009-FY2013
  • Revenue Breakdown of Medtronic (by Product), FY2009-FY2013
  • Revenue Structure of Medtronic (by Product), FY2009-FY2013
  • Medtronic's Revenue from Coronary Artery Products and % of Total Revenue, FY2009-FY2013
  • Revenue, Net Income and Gross Margin of Boston Scientific, 2009-2013
  • Revenue Breakdown of Boston Scientific (by Division), 2009-2013
  • Revenue Breakdown of Boston Scientific (by Region), 2009-2013
  • Boston Scientific's Revenue from Cardiovascular Division and YoY Growth, 2009-2013
  • Revenue, Net Income and Gross Margin of Abbott, 2009-2013
  • Revenue Breakdown of Abbott (by Product), 2009-2013
  • Revenue Structure of Abbott (by Product), 2009-2013
  • Revenue from Cardiovascular Products and % of Total Revenue, 2009-2013
  • Revenue, Net Income and Gross Margin of B. Braun, 2009-2013
  • Revenue Breakdown of B. Braun (by Division), 2009-2013
  • Revenue Breakdown of B. Braun (by Region), 2009-2013
  • Revenue and YoY Growth of B. Braun's Aesculap Division, 2009-2013
  • Revenue and Net Income of Terumo, FY2010-FY2013
  • Revenue of Terumo by Business, FY2010-FY2013
  • Revenue of Terumo by Region, FY2010-FY2013
  • R&D Cost and Proportion in Revenue of Terumo, FY2010-FY2013
  • Revenue from Cardiovascular Business and Revenue Share of Terumo, FY2010-FY2013
  • PTCA Balloon Dilatation Catheter Output and YoY Growth of Terumo, FY2009-FY2013
  • Angiographic Guidewire Output and YoY Growth of Terumo, FY2009-FY2013
  • PTCA Guidewire Output and YoY Growth of Terumo, FY2009-FY2013
  • China Branches and Their Business of Terumo
  • Terumo's Layout in China
  • Revenue, Net Income and Gross Margin of MicroPort, 2009-2013
  • Revenue Breakdown of MicroPort (by Product), 2011-2013
  • Revenue Structure of MicroPort (by Product), 2011-2013
  • Revenue Breakdown of MicroPort (by Region), 2009-2013
  • Revenue Structure of MicroPort (by Region), 2009-2013
  • MicroPort's Revenue from Interventional Cardiovascular Products and % of Total Revenue, 2011-2013
  • MicroPort's Advantages in Heart Drug-eluting Stent Field
  • R&D Costs and % of Total Revenue of MicroPort, 2009-2013
  • Revenue and Net Income of MicroPort, 2012-2017E
  • Distribution of Lepu Medical's Subsidiaries
  • Revenue, Net Income and Gross Margin of Lepu Medical, 2009-2013
  • Revenue Breakdown of Lepu Medical (by Product), 2009-2013
  • Revenue Breakdown of Lepu Medical (by Region), 2009-2013
  • Gross Margin of Lepu Medical (by Product), 2009-2013
  • R&D Costs and % of Total Revenue of Lepu Medical, 2010-2013
  • Lepu Medical's Projects with Raised Funds and Progress
  • Revenue and Net Income of Lepu Medical, 2012-2017E
  • Revenue, Net Income and Gross Margin of Lifetech Scientific, 2009-2013
  • Revenue Breakdown of Lifetech Scientific (by Business), 2009-2013
  • Revenue Structure of Lifetech Scientific (by Business), 2009-2013
  • Lifetech Scientific's Revenue from Congenital Heart Disease Business, YoY Growth and % of Total Revenue, 2009-2013
  • Lifetech Scientific's Revenue from Peripheral Vascular Disease Business, YoY Growth and % of Total Revenue, 2009-2013
  • R&D Costs, YoY Growth and % of Total Revenue of Lifetech Scientific, 2010-2013
  • Revenue and Net Income of Lifetech Scientific, 2012-2017E
  • Balloon Compliance of JW Medical's EXCEL Drug-eluting Stent Delivery System
  • Features of Dalian Yinyi's Balloon Dilatation Catheters
  • Technical Parameters of COMBO Dual Therapy Stent
  • SCW Medicath's PTCA Balloon Dilatation Catheters
  • Features and Advantages of SCW Medicath's PTCA Balloon Dilatation Catheters
  • Technical Parameters of SCW Medicath's PTCA Balloon Dilatation Catheters
  • Technical Parameters of Demax Medical's Gusta PTCA Balloon Dilatation Catheters
  • Technical Parameters of Demax Medical's Gusta PTCA Non-compliance Balloon Dilatation Catheters
  • Main Technical Parameters of Synexmed's Advancer PTCA Balloon Catheter
  • Main Technical Parameters of Synexmed's Advancer Plus PTCA/CTO Balloon Catheter
  • Main Technical Parameters of Synexmed's Advancer Hp High Pressure Balloon Catheter
  • Technical Parameters of Synexmed's RUNNER Coronary Stent
  • Technical Parameters of Synexmed's CHALLENGER Coronary Stent
  • Technical Parameters of Synexmed's RAPA Rapamycin Drug-eluting Coronary Stent
  • Technical Parameters of Sino Medical's BuMA Drug-eluting Stent
  • Technical Parameters of Sino Medical's SUN Coronary Stent
  • Diagram for Balloon Passing External Diameter of Sino Medical's Sleek PTCA Rapid Exchange Dilatation Balloon Catheter
  • Market Size and YoY Growth of China Interventional Cardiovascular Device Industry, 2012-2017E
Back to Top